TCL Archive FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA July 3, 1981
TCL Archive IOM Omics Committee Offers Blueprint to Prevent Other Duke-Style Disasters March 23, 2012
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer October 6, 1989
TCL Archive FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe December 5, 1986
